Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Reinforcement of the Impact of a Functional Insulin Therapy Training Course by Telemonotoring With a PDA-phone in Type 1 Diabetic Patients. The TELFIT Study Patients (TELFIT)

10. marts 2010 opdateret af: University Hospital, Grenoble

Reinforcement of the Impact of a Functional Insulin Therapy Training Course by Telemonotoring With a PDA-phone in Type 1 Diabetic Patients. The TELFIT Study

TELFIT is a monocenter, controlled, randomised trial. It focuses on type 1 diabetes patients that have attended a functional insulin therapy training course. The Primary objective of the TELFIT study is to evaluate whether a PDA with telemonitoring by phone reinforces the effects of the functional insulin therapy training course as compared with conventional care.

Main judgment criteria: comparison of HbA1c means between M0 (start) and M3(3 months)

Studieoversigt

Status

Afsluttet

Detaljeret beskrivelse

All patients will attend a functional insulin therapy training course and be randomized into 2 groups. One group will receive a PDA-phone and one month of phone consultations with a nurse and a physician. The other group will only have the usual paper support. This study compares the evolution of HbA1c in the 2 groups over a period of 3 months. It also assesses time spent by nurses and physicians, changes in quality of life, hypoglycaemia frequency and weight changes.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

62

Fase

  • Fase 3

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Grenoble, Frankrig, 38043
        • University Hospital Grenoble

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Type 1 diabetes mellitus for ≥ 6 months or more
  • Age > 18 year old
  • The patient has attended a functional insulin therapy class or workshop
  • Insulin basal-bolus therapy for at least 6 months. At inclusion, patients should be treated either with a long-acting insulin and insulin rapid analog before each meal, or with rapid insulin analog delivered with a pump
  • Ability to understand how the PDA-phone works and ability to use it
  • Social Security membership or benefit from Social Security
  • Patients equipped with a memory blood glucose monitor
  • Informed consent, with a signed and approved form

Exclusion Criteria:

  • Underage patient, major patient under guardianship or protected by the Law
  • Patient with any unstable associated evolutive pathology that could cause a diabetes imbalance within the coming year
  • Change in diabetes treatment within the 3 months before inclusion or planned during the study
  • Patient who needs a more frequent diabetic follow-up than in the protocol (especially severe or evolving complication due to diabetes)
  • Patient attending another education program within the 3 months before inclusion or planning to attend one during the study
  • Patient with toxicomania, alcoholism or psychological troubles that could impact the study
  • Type-2-diabetic patient
  • Patient who doesn't need strict metabolic objectives
  • Pregnant or possibly pregnant woman
  • Person with no freedom (prisoner)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: 1
Patients will have face to face visits at 3 months and no PDA-phone. Patients will record glycemia on paper support
Patients will have face to face visits at 3 months and no PDA-phone. Patients will record glycemia on paper support.
Eksperimentel: 2
PDA-phone + phone consultations + standard visit at 3 months
Patients will received PDA-phone + a telephone follow up + standard visit at 3 months

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
Comparison of HbA1c means
Tidsramme: M0 (start) and M3 (3 months)
M0 (start) and M3 (3 months)

Sekundære resultatmål

Resultatmål
Tidsramme
Difference between theoretical insulin dose and actual dose, one week before the 3-month reevaluation session
Tidsramme: M0 (start) and M3 (3 months)
M0 (start) and M3 (3 months)
DHP scale of quality of life and satisfaction dimension of the DQOL questionnaire
Tidsramme: M0 (start) and M3 (3 months)
M0 (start) and M3 (3 months)
Time spent by physicians and nurses in the different groups
Tidsramme: M0 (start) and M3 (3 months)
M0 (start) and M3 (3 months)
Weight changes during the 3-month period
Tidsramme: M0 (start) and M3 (3 months)
M0 (start) and M3 (3 months)
Number of hypoglycemias (moderate and severe) during the 3-month period
Tidsramme: M0 (start) and M3 (3 months)
M0 (start) and M3 (3 months)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Pierre Y Benhamou, PhD, University Hospital, Grenoble

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. juli 2008

Primær færdiggørelse (Faktiske)

1. marts 2010

Studieafslutning (Faktiske)

1. marts 2010

Datoer for studieregistrering

Først indsendt

19. september 2008

Først indsendt, der opfyldte QC-kriterier

22. september 2008

Først opslået (Skøn)

23. september 2008

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

11. marts 2010

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

10. marts 2010

Sidst verificeret

1. marts 2010

Mere information

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner